-
1
-
-
1842684996
-
Nanomedicines for overcoming biological barriers
-
M. J. Alonso, Nanomedicines for overcoming biological barriers. Biomed. Pharmacother. 58, 168 (2004).
-
(2004)
Biomed. Pharmacother
, vol.58
, pp. 168
-
-
Alonso, M.J.1
-
2
-
-
29144450682
-
Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents
-
G. Zheng, J. Chen, H. Li, and J. D. Glickson, Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl. Acad. Sci. USA 102, 17757 (2005).
-
(2005)
Proc. Natl. Acad. Sci. USA
, vol.102
, pp. 17757
-
-
Zheng, G.1
Chen, J.2
Li, H.3
Glickson, J.D.4
-
3
-
-
0037462997
-
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
-
J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329 (2003).
-
(2003)
Adv. Drug Deliv. Rev
, vol.55
, pp. 329
-
-
Panyam, J.1
Labhasetwar, V.2
-
4
-
-
0034996764
-
Long-circulating and target-specific nanoparticles: Theory to practice
-
S. M. Moghimi, A. C. Hunter, and J. C. Murray, Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53, 283 (2001).
-
(2001)
Pharmacol. Rev
, vol.53
, pp. 283
-
-
Moghimi, S.M.1
Hunter, A.C.2
Murray, J.C.3
-
5
-
-
0035966497
-
Biodegradable polymeric nanoparticles as drug delivery devices
-
K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70, 1 (2001).
-
(2001)
J. Control. Release
, vol.70
, pp. 1
-
-
Soppimath, K.S.1
Aminabhavi, T.M.2
Kulkarni, A.R.3
Rudzinski, W.E.4
-
7
-
-
0038309868
-
Physico-chemical stability of colloidal lipid particles
-
B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, and J. P. Benoit, Physico-chemical stability of colloidal lipid particles. Biomaterials 24, 4283 (2003).
-
(2003)
Biomaterials
, vol.24
, pp. 4283
-
-
Heurtault, B.1
Saulnier, P.2
Pech, B.3
Proust, J.E.4
Benoit, J.P.5
-
8
-
-
0031469673
-
The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent
-
M. P. Desai, V. Labhasetwar, E. Walter, R. J. Levy, and G. L. Amidon, The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14, 1568 (1997).
-
(1997)
Pharm. Res
, vol.14
, pp. 1568
-
-
Desai, M.P.1
Labhasetwar, V.2
Walter, E.3
Levy, R.J.4
Amidon, G.L.5
-
9
-
-
26944494899
-
Formulation and investigation of 5-FU nanoparticles with factorial design-based studies
-
A. Bozkir and O. M. Saka, Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. Parmaco 60, 840 (2005).
-
(2005)
Parmaco
, vol.60
, pp. 840
-
-
Bozkir, A.1
Saka, O.M.2
-
10
-
-
29244442282
-
Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design
-
M. D. Bhavsar, S. B. Tiwari, and M. M. Arniji, Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J. Control. Release 110, 422 (2006).
-
(2006)
J. Control. Release
, vol.110
, pp. 422
-
-
Bhavsar, M.D.1
Tiwari, S.B.2
Arniji, M.M.3
-
11
-
-
0037093720
-
A factorial design study
-
Biocompatible stabilizers in the preparation of PLGA nanoparticles
-
J. Vandervoort and A. Ludwig, Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study. Int. J. Pharm. 238, 77 (2002).
-
(2002)
Int. J. Pharm
, vol.238
, pp. 77
-
-
Vandervoort, J.1
Ludwig, A.2
-
12
-
-
0032743871
-
Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly (isobutylcyanoacrylate) nanoparticles
-
P. A. McCarron, A. D. Woolfson, and S. M. Keating, Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly (isobutylcyanoacrylate) nanoparticles. Int. J. Pharm. 193, 37 ( 1999).
-
(1999)
Int. J. Pharm
, vol.193
, pp. 37
-
-
McCarron, P.A.1
Woolfson, A.D.2
Keating, S.M.3
-
13
-
-
0036848464
-
Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles
-
J. X. Wang, X. Sun, and Z. R. Zhang, Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J. Pharm. Biopharm. 54, 285 (2002).
-
(2002)
Eur J. Pharm. Biopharm
, vol.54
, pp. 285
-
-
Wang, J.X.1
Sun, X.2
Zhang, Z.R.3
-
14
-
-
1942453805
-
Solid lipid nanoparticles for parenteral drug delivery
-
S. A. Wissing, O. Kayser, and R. H. Muller, Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56, 1257 ( 2004).
-
(2004)
Adv. Drug Deliv. Rev
, vol.56
, pp. 1257
-
-
Wissing, S.A.1
Kayser, O.2
Muller, R.H.3
-
15
-
-
0035946615
-
Solid lipid nanoparticles: Production, characterization and applications
-
W. Mehnert and K. Mader, Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165 (2001).
-
(2001)
Adv. Drug Deliv. Rev
, vol.47
, pp. 165
-
-
Mehnert, W.1
Mader, K.2
-
16
-
-
3242716580
-
Cystatin incorporated in poly (lactide-co-glycolide) nanoparticles: Development and fundamental studies on preservation of its activity
-
M. Cegnar, J. Kos, and J. Kristl, Cystatin incorporated in poly (lactide-co-glycolide) nanoparticles: Development and fundamental studies on preservation of its activity. Eur. J. Pharm. Sci. 22, 357 (2004).
-
(2004)
Eur. J. Pharm. Sci
, vol.22
, pp. 357
-
-
Cegnar, M.1
Kos, J.2
Kristl, J.3
-
17
-
-
0031960740
-
Influence of formulation variables
-
Ultrasound-induced degradation of PLA and PLGA during microsphere processing
-
G. Reich, Ultrasound-induced degradation of PLA and PLGA during microsphere processing: Influence of formulation variables. Eur. J. Pharm. Biopharm. 45, 165 (1998).
-
(1998)
Eur. J. Pharm. Biopharm
, vol.45
, pp. 165
-
-
Reich, G.1
-
18
-
-
0032950389
-
Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain
-
S. C. Yang, L. F. Lu, Y. Cai, J. B. Zhu, B. W. Liang, and C. Z. Yang, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Release 59, 299 (1999).
-
(1999)
J. Control. Release
, vol.59
, pp. 299
-
-
Yang, S.C.1
Lu, L.F.2
Cai, Y.3
Zhu, J.B.4
Liang, B.W.5
Yang, C.Z.6
-
19
-
-
0141867753
-
Ultrasonication of chitosan and chitosan nanoparticles
-
E. S. Tang, M. Huang, and L. Y. Lim, Ultrasonication of chitosan and chitosan nanoparticles. Int. J. Pharm. 265, 103 (2003).
-
(2003)
Int. J. Pharm
, vol.265
, pp. 103
-
-
Tang, E.S.1
Huang, M.2
Lim, L.Y.3
-
20
-
-
12344337457
-
Effect of formulation variables on size distribution
-
PLGA nanoparticles containing praziquantel
-
R. M. Mainardes and R. C. Evangelista, PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int. J. Pharm. 290, 137 (2005).
-
(2005)
Int. J. Pharm
, vol.290
, pp. 137
-
-
Mainardes, R.M.1
Evangelista, R.C.2
-
21
-
-
33947188787
-
Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres
-
S. Mao, J. Xu, C. Cai, O. Germershaus, A. Schaper, and T. Kissel, Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int. J. Pharm. 334, 137 ( 2007).
-
(2007)
Int. J. Pharm
, vol.334
, pp. 137
-
-
Mao, S.1
Xu, J.2
Cai, C.3
Germershaus, O.4
Schaper, A.5
Kissel, T.6
-
22
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
-
R. H. Muller, K. Mader, and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161 (2000).
-
(2000)
Eur. J. Pharm. Biopharm
, vol.50
, pp. 161
-
-
Muller, R.H.1
Mader, K.2
Gohla, S.3
-
23
-
-
33846640781
-
Preparation and in vitro evaluation
-
Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles
-
A. Yang, L. Yang, W. Liu, Z. Li, H. Xu, and X. Yang, Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and in vitro evaluation. Int. J. Pharm. 331, 123 (2007).
-
(2007)
Int. J. Pharm
, vol.331
, pp. 123
-
-
Yang, A.1
Yang, L.2
Liu, W.3
Li, Z.4
Xu, H.5
Yang, X.6
-
24
-
-
33645839863
-
Study and formation of vesicle systems with low polydispersity index by ultrasound method
-
J. Pereira-Lachataignerais, R. Pons, P. Panizza, L. Courbin, J. Rouch, and O. Lopez, Study and formation of vesicle systems with low polydispersity index by ultrasound method. Chem. Phys. Lipids 140, 88 (2006).
-
(2006)
Chem. Phys. Lipids
, vol.140
, pp. 88
-
-
Pereira-Lachataignerais, J.1
Pons, R.2
Panizza, P.3
Courbin, L.4
Rouch, J.5
Lopez, O.6
-
25
-
-
33646081517
-
Preparation and characteristics of monostearin nanostructured lipid carriers
-
F. Q. Hu, S. P. Jiang, Y. Z. Du, H. Yuan, Y. Q. Ye, and S. Zeng, Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 314, 83 (2006).
-
(2006)
Int. J. Pharm
, vol.314
, pp. 83
-
-
Hu, F.Q.1
Jiang, S.P.2
Du, Y.Z.3
Yuan, H.4
Ye, Y.Q.5
Zeng, S.6
|